Analysis of current perioperative management with Haemate® P/Humate P® in von Willebrand disease
Identifying the need for personalized treatment
Introduction: Patients with Von Willebrand disease (VWD) are regularly treated with VWF-containing concentrates in case of acute bleeding, trauma and dental or surgical procedures.
Aim: In this multicentre retrospective study, current perioperative management with a von Willebrand factor (VWF)/Factor VIII (FVIII) concentrate (Haemate® P) in patients with VWD was evaluated. Patients/Methods: Patients with VWD undergoing minor or major surgery between 2000 and 2015, requiring treatment with a VWF/FVIII concentrate (Haemate® P), were included. Achieved VWF activity (VWF:Act) and FVIII during FVIII-based treatment regimens were compared to predefined target levels in national guidelines.
Results: In total, 103 patients with VWD (148 surgeries) were included: 54 type 1 (73 surgeries), 43 type 2 (67 surgeries) and 6 type 3 (8 surgeries). Overall, treatment resulted in high VWF:Act and FVIII levels, defined as ≥0.20 IU/mL above predefined levels. In patients with type 1 VWD, respectively, 65% and 91% of trough VWF:Act and FVIII levels were higher than target levels. In patients with type 2 and type 3 VWD, respectively, 53% and 57% of trough VWF:Act and 72% and 73% of trough FVIII levels were higher than target level. Furthermore, FVIII accumulation over time was observed, while VWF:Act showed a declining trend, leading to significantly higher levels of FVIII than VWF:Act.
Conclusion: High VWF:Act and accumulation of FVIII were observed after perioperative FVIII-based replacement therapy in patients with VWD, both underlining the necessity of personalization of dosing regimens to optimize perioperative treatment.
|Keywords||Individualized medicine, Surgery, Therapy, Von Willebrand Disease, Von Willebrand factor (MESH entry database)|
|Persistent URL||dx.doi.org/10.1111/hae.13451, hdl.handle.net/1765/105432|
Hazendonk, H.C.A.M, Heijdra, J.M, de Jager, N.C.B., Veerman, H.C, Boender, J, Van Moort, I, … Cnossen, M.H. (2018). Analysis of current perioperative management with Haemate® P/Humate P® in von Willebrand disease. Haemophilia. doi:10.1111/hae.13451